| Powder: | Yes |
|---|---|
| Customized: | Customized |
| Certification: | GMP, HSE, ISO 9001, USP, BP |
| Suitable for: | Elderly, Adult |
| State: | Solid |
| Purity: | >99% |
| Samples: |
|---|
| Customization: |
|---|
Suppliers with verified business licenses
Audited Supplier 
English name: Dehydronandrolon
CAS: 2590-41-2
Formula: C20H26O3
Molecular Weight: 314.42
Molecular Structure:
Assay:99%
Appearance: White crystalline powder.
Dehydronandrolone acetate is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug (around 8 days). Users report mild side effects, with the biggest side effect being water retention.
Dehydronandrolon acetate is a key intermediate for the synthesis of ( while the former was an anti-breast-cancer drug developed by AstraZeneca Company and the latter was a synthetic steroid marketed by Organon Company for post climacteric complains. It is an effective compound that produces quality, long-lasting muscle gains. This is because of the relatively long half-life of the drug. Users report mild side effects, with the biggest side effect being water retention.
Dehydronandrolone Acetate COA :
| Product name | Dehydronandrolon | |||
| CAS No. | 2590-41-2 | Outer Packing | 1KG | |
| Production date | 2015.07.28 | Shelf life | 2018.07.27 | |
| Standard adopted | In House standard | |||
| Items of analysis | Specification | Results | ||
| Description | White to light yellow crystalline powder | White crystalline powder | ||
| Melting Point | ≥100ºC | 107ºC | ||
| Specific optical rotation | -20°~-26° | -22.5° | ||
| Loss on Drying | ≤0.5% | 0.15% | ||
| Identification | Test preparation has maximum absorption at 282±2nm by ultraviolet - visible spectrophotometry. | Qualified | ||
| Maximum single impurity | ≤1.0% | 0.3% | ||
| Total impurities | ≤5.0% | 0.8% | ||
| Assay | ≥95.0% | 99.45% | ||
| Conclusion | Qualified | |||
Suppliers with verified business licenses
Audited Supplier 
){kind=link}
){kind=link}